Skip to main content

CYTARABINE

NDC 61703-303 · Hospira, Inc.

Generic nameCYTARABINE
Dosage formINJECTION, SOLUTION
RouteINTRAVENOUS
Active ingredient(s)CYTARABINE
Strength20 mg/mL
Pharmacologic classNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
Marketing categoryANDA

Packages

61703-303-46 — 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (61703-303-46) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE

Billed under HCPCS

J9100 — Injection, cytarabine, 100 mg Medicare Part B payment limit (ASP + 6%): $0.85

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

25021-223 — cytarabine, 25021-229 — cytarabine, 61703-155 — CYTARABINE, 61703-304 — CYTARABINE, 61703-305 — CYTARABINE, 61703-319 — CYTARABINE, 63323-120 — CYTARABINE, 68083-337 — Cytarabine, 68083-343 — Cytarabine, 68727-745 — (daunorubicin and cytarabine) liposome, 71288-108 — Cytarabine, 71288-109 — Cytarabine, 71288-168 — Cytarabine, 71288-169 — Cytarabine

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.